Please assess the completion status of the following clinical trial:

Trial Title: Correlation of Endothelial Function and Early Coronary Artery Disease in Humans

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \> 18 years and \< 85 years~* Male or female~Exclusion criteria:~* Left dominant circulation~* Heart failure with EF \<40%~* Unstable angina~* MI or angioplasty of the LAD or circumflex with 6 months prior to entry into the study~* Use of radiographic contrast agent within 12 hours of entry into the study~* Use of investigational agents within one month of entry into the study~* Patients who require treatment with positive inotropic agents other than digoxin during the study~* Patients with cerebrovascular accident within 6 months prior to entry into the study~* Significant endocrine, hepatic, renal disorders; local or systemic infectious disease within 4 weeks prior to entry into study~* Pregnancy or lactation~* Mental instability~* Federal Medical Center patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- I (Type: ACTIVE_COMPARATOR): Qualifying patients took Atrasentan, 1 pill per day for 6 months, to determine if it had a favorable affect on patients who took it over those who were randomized to placebo.
- 2 (Type: PLACEBO_COMPARATOR): placebo group to be compared to the actual medication

Based on this trial design, predict the completion outcome and termination type (if applicable).